Jing Qian

Title: Jing Qian: Innovator in Estrogen and Androgen Receptor Modulation

Introduction

Jing Qian is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of estrogen and androgen receptors. With a total of 2 patents, her work has the potential to impact the treatment of various hormone-related diseases.

Latest Patents

Jing Qian's latest patents include innovative methods and compositions for modulating estrogen receptor mutants. These patents describe methods for treating ER-related diseases characterized by mutations in the ESR1 gene through the administration of estrogen receptor modulators. Additionally, her work addresses hormone-resistant estrogen receptor-positive breast cancers, providing new avenues for treatment. Another notable patent focuses on determining resistance to androgen receptor therapy. This patent outlines modified androgen receptor polypeptides that resist inhibition by androgen receptor inhibitors, along with methods for using these polypeptides as screening agents for third-generation androgen receptor modulators.

Career Highlights

Throughout her career, Jing Qian has worked with leading companies in the pharmaceutical industry, including Aragon Pharmaceuticals, Inc. and Genentech, Inc. Her experience in these organizations has allowed her to develop and refine her innovative approaches to receptor modulation.

Collaborations

Jing Qian has collaborated with notable colleagues, including James David Joseph and Nicholas D. Smith. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Jing Qian's contributions to the field of receptor modulation are noteworthy and demonstrate her commitment to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in the industry.